CCL2 and adenocarcinoma: In order to study the role of CCL2 in a network consisting of tumor cells, MSCs, and TAMs in the TME, we disrupted the CCL2 gene in the transgenic adenocarcinoma of the mouse prostate (TRAMP)-C2 cell line [27].